Andera Partners
EdRip acquires Acto Mezzanine from ACG Capital
ACG had acquired the activity from Groupama Private Equity in 2013
Pragma Capital exits Nasse-Demeco to Siparex
Pragma Capital had supported the buyout of the removal company back in 2007
IK Investment Partners invests in B2S
IK made the investment through its Small Cap Fund I buyout vehicle, securing a minority stake
EdRip leads €34m series-B for MedDay
French biotech is to begin the third US testing phase for its multiple sclerosis drug
EdRip backs SFAM with €10-20m injection
Deal is the ninth to be financed via the GP’s €300m small-cap venture fund, Winch Capital 3
PE-backed Marietton bolts-on Havas Voyage
Siparex and EdRip to hold joint controlling stake in post-merger group
EdRip leads €15m round for GamaMabs Pharma
InnoBio, Irdinov, Alto Invest and Ixo Private Equity also take part in capital increase
Rothschild launches €30m feeder fund-of-funds
Vehicle to back six of the GP’s funds
Deal in focus: Ardian exit sparks third reshuffle for Novarc
An in-depth look at Ardian's recent exit of electrical business Novarc
PE-backed Smile to bolt on Open Wide
Resulting group to employ 1,000 and generate €70m turnover
EdRip backs Realease Capital via Cabestan fund
Company generated €60m turnover in 2014
Rothschild to launch €250-300m fund as part of PE push
GP to bolster PE team with new head of investor relations
Pragma et al. to sell Nasse-Demeco
Exit plans come eight years after GP picked up majority stake
EdRip invests in Erget buyout
GP takes minority stake via Cabestan fund
EdRip exits Novamex to Sodalis
GP acquired 25% stake in March 2011
EdRip et al. exit Prozone in trade sale
US buyer Stats is owned by Vista Equity Partners
EdRip secures 10% stake in Altavia
Fifth investment for €300m Winch Capital 3 Fund
EdRip in exclusive talks for LBO Partners’ Rougnon
LBO intends to fully exit its minority stake in the business
EdRip and Phillimore exit Ocean to Orange
Company turnover up 15% since 2011 buyout
Rothschild backs ACE Group
Company plans to double number of existing offices
Omnes to reap 5x return on Exclusive Networks exit
Cobepa beats private equity suitors to clinch deal
EdRip backs Eurogiciel BIMBO
Financing provided by banking pool, mezz by Trocadero Capital
VC backers divest GlycoVaxyn to GSK
Deal values biopharmaceutical company at $212m
NeoMed leads CHF 20m Genkyotex financing
VI Partners and BioMedInvest are co-investors